These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 7933033)
1. Doppler flow evaluation of pathologic endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen. Tepper R; Cohen I; Altaras M; Shapira J; Cordoba M; Dror Y; Beyth Y J Ultrasound Med; 1994 Aug; 13(8):635-40. PubMed ID: 7933033 [TBL] [Abstract][Full Text] [Related]
2. The role of ultrasound in the detection of endometrial pathologies in asymptomatic postmenopausal breast cancer patients with tamoxifen treatment. Cohen I; Beyth Y; Tepper R Obstet Gynecol Surv; 1998 Jul; 53(7):429-38. PubMed ID: 9662729 [TBL] [Abstract][Full Text] [Related]
3. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study. Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921 [TBL] [Abstract][Full Text] [Related]
4. Limitations of transvaginal sonography and color Doppler imaging in the differentiation of endometrial carcinoma from benign lesions. Chan FY; Chau MT; Pun TC; Lam C; Ngan HY; Leong L; Wong RL J Ultrasound Med; 1994 Aug; 13(8):623-8. PubMed ID: 7933031 [TBL] [Abstract][Full Text] [Related]
5. Sonohysterography compared with endometrial biopsy for evaluation of the endometrium in tamoxifen-treated women. Hann LE; Kim CM; Gonen M; Barakat R; Choi PH; Bach AM J Ultrasound Med; 2003 Nov; 22(11):1173-9. PubMed ID: 14620887 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen. Bornstein J; Auslender R; Pascal B; Gutterman E; Isakov D; Abramovici H J Reprod Med; 1994 Sep; 39(9):674-8. PubMed ID: 7807477 [TBL] [Abstract][Full Text] [Related]
7. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen. Hann LE; Gretz EM; Bach AM; Francis SM AJR Am J Roentgenol; 2001 Aug; 177(2):337-42. PubMed ID: 11461858 [TBL] [Abstract][Full Text] [Related]
8. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586 [TBL] [Abstract][Full Text] [Related]
9. Histopathologic findings in thickened endometria, as measured by ultrasound in asymptomatic, postmenopausal breast cancer patients on various adjuvant treatment including tamoxifen. Willén R; Lindahl B; Andolf E; Ingvar C; Liedman R; Ranstam J Anticancer Res; 1998; 18(1B):667-76. PubMed ID: 9584050 [TBL] [Abstract][Full Text] [Related]
10. Transvaginal US and hysterosonography in postmenopausal women with breast cancer receiving tamoxifen: correlation with hysteroscopy and pathologic study. Fong K; Causer P; Atri M; Lytwyn A; Kung R Radiographics; 2003; 23(1):137-50; discussion 151-5. PubMed ID: 12533649 [TBL] [Abstract][Full Text] [Related]
11. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study. Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913 [TBL] [Abstract][Full Text] [Related]
12. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Kedar RP; Bourne TH; Powles TJ; Collins WP; Ashley SE; Cosgrove DO; Campbell S Lancet; 1994 May; 343(8909):1318-21. PubMed ID: 7910323 [TBL] [Abstract][Full Text] [Related]
13. Different coexisting endometrial histological features in asymptomatic postmenopausal breast cancer patients treated with tamoxifen. Cohen I; Altaras MM; Shapira J; Tepper R; Cordoba M; Figer A; Zalel Y; Dror Y; Beyth Y Gynecol Obstet Invest; 1997; 43(1):60-3. PubMed ID: 9015703 [TBL] [Abstract][Full Text] [Related]
14. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients. Cheng WF; Lin HH; Torng PL; Huang SC Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568 [TBL] [Abstract][Full Text] [Related]
15. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow. Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941 [TBL] [Abstract][Full Text] [Related]
16. Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen. Cecchini S; Ciatto S; Bonardi R; Mazzotta A; Grazzini G; Pacini P; Muraca MG Gynecol Oncol; 1996 Mar; 60(3):409-11. PubMed ID: 8774648 [TBL] [Abstract][Full Text] [Related]
17. [Clinical value of the measurement of blood flow in uterine arteries and endometrial vessels in women with postmenopausal bleeding using "power" angio Doppler technique]. Englert-Golon M; Szpurek D; Moszyński R; Pawlak M; Sajdak S Ginekol Pol; 2006 Oct; 77(10):759-63. PubMed ID: 17219807 [TBL] [Abstract][Full Text] [Related]
18. Transvaginal color and pulsed Doppler sonography of the endometrium: a possible role in reducing the number of dilatation and curettage procedures. Aleem F; Predanic M; Calame R; Moukhtar M; Pennisi J J Ultrasound Med; 1995 Feb; 14(2):139-45; quiz 147-8. PubMed ID: 8568960 [TBL] [Abstract][Full Text] [Related]